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Abstract
Background: Suboptimal treatment adherence remains a barrier to the control of many infectious
diseases, including tuberculosis and HIV/AIDS, which contribute significantly to the global disease
burden. However, few of the many interventions developed to address this issue explicitly draw on
theories of health behaviour. Such theories could contribute to the design of more effective
interventions to promote treatment adherence and to improving assessments of the transferability
of these interventions across different health issues and settings.
Methods: This paper reviews behaviour change theories applicable to long-term treatment
adherence; assesses the evidence for their effectiveness in predicting behaviour change; and
examines the implications of these findings for developing strategies to improve TB and HIV/AIDS
medication adherence. We searched a number of electronic databases for theories of behaviour
change. Eleven theories were examined.
Results: Little empirical evidence was located on the effectiveness of these theories in promoting
adherence. However, several models have the potential to both improve understanding of
adherence behaviours and contribute to the design of more effective interventions to promote
adherence to TB and HIV/AIDS medication.
Conclusion: Further research and analysis is needed urgently to determine which models might
best improve adherence to long-term treatment regimens.
Background
Theories may assist in the design of behaviour change
interventions in various ways [1-3], by promoting an
understanding of health behaviour, directing research and
facilitating the transferability of an intervention from one
health issue, geographical area or healthcare setting to
another.
Ensuring treatment adherence presents a considerable
challenge to health initiatives. Haynes et al. ([4], p2) have
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defined adherence as "the extent to which patients follow
the instructions they are given for prescribed treatments".
Adherence is a more neutral term than 'compliance',
which can be construed as being judgmental. While pro-
grammes promoting adherence have focused on various
health behaviours, this review focuses specifically on
long-term adherence to tuberculosis (TB) and HIV/AIDS
treatment. Non-adherence to treatment for these diseases
has severe human, economic and social costs. Interrupted
treatment may reduce treatment efficacy and cause drug
resistance [5], resulting in increased morbidity and mor-
tality and further infections. Without intervention, adher-
ence rates to long-term medication in high income
countries are approximately 50% [6], while adherence in
low and middle income countries may be even lower [7].
TB and HIV present particular challenges to adherence.
Both are chronic and infectious diseases that affect mainly
the most disadvantaged populations and involve complex
treatment regimens with potentially severe side effects;
both are public health priorities and non-adherence may
cause drug resistance [7]. These characteristics differenti-
ate these diseases from other chronic diseases such as
asthma and hypertension where, for example, drug resist-
ance is not a key issue. Treatment adherence is also
affected by beliefs about the origins, transmission and
treatment of TB and HIV, often resulting in the stigmatisa-
tion of those affected [7]. The interaction of these factors
make adherence for these diseases not only a priority but
a complex health issue.
Various interventions have been designed to improve
treatment adherence, but few theories describe specifically
the processes involved. Currently, there are more than 30
psychological theories of behaviour change [8], making it
difficult to choose the most appropriate one when design-
ing interventions. This is a particular problem within the
field of adherence to long-term medications, where the
consequences of non-adherence may be severe. Existing
theories therefore need to be examined further to deter-
mine their relevance to the issue of long-term medication
adherence.
Leventhal and Cameron [9] identified five main theoreti-
cal perspectives related to adherence: 1) biomedical; 2)
behavioural; 3) communication; 4) cognitive; and 5) self-
regulatory. Each perspective encompasses several theories.
More recently, the stage perspective has emerged, which
includes the transtheoretical model. The most commonly
used theories are those within the cognitive perspective
[1,10] and the transtheoretical model [1]. This review
includes a short description of theories within each of the
five perspectives listed above, as well as the transtheoreti-
cal model. We locate these theories specifically within the
realm of adherence to long-term medication, defined as
medication regimens of three months or more; describe
their key characteristics and evidence base; and examine
their relevance and applicability with regard to adherence
to long-term medication regimens for TB and HIV/AIDS.
To our knowledge, the area of long-term adherence to
medication has not yet been addressed in reviews of
health behaviour theories.
While the focus of this review is on factors affecting con-
sumers, we acknowledge that adherence is a complex and
dynamic phenomenon, which relates to consumers, pro-
viders, health systems and broader socio-economic and
political contexts. Although the theories chosen for this
review focus mainly on providers and consumers, this is
not the only area in which adherence can be promoted.
The review is intended as an information source for those
wishing to develop theory-based interventions focusing
on intra- or interpersonal factors to increase TB and/or
HIV treatment adherence.
Methods
A search was performed on MEDLINE, CINAHL, Pre-
CINAHL, PsycInfo, ScienceDirect and ERIC databases
using the keywords 'health and behaviour and (model or
theory)'; '(model or theory); (adherence or concordance
or compliance)', from the start date of each database to
February 2005. Additional searches were performed in the
University of Cape Town library, Google and Google
Scholar. Citations were also identified from included
papers. Finally, all databases consulted were searched
again using the names of theories as keywords, with
'meta-analysis' or 'systematic review' in April 2005.
Experts were consulted for comments and references. Pub-
lished articles or book chapters in English, describing a
particular theory, and articles that presented a meta-anal-
ysis of the theory, were included. Articles were excluded if
they did not satisfy the aforementioned criteria. Where
possible, interventions related to TB or HIV adherence
were identified. No authors were contacted. Several addi-
tional randomised controlled studies or other articles
were also included as examples of the use of theories in
intervention development. In this paper we use the term
'theory', instead of 'model', and the term 'variable',
instead of 'construct', when referring to a part of the the-
ory.
Results
Table 1 presents the theories included in this article and
references to meta-analyses synthesizing the evidence for
each. Below, we summarise each perspective and the the-
ories within it and provide examples of its application to
adherence behaviours [see additional file 1]. We then
examine the usefulness of these theories in developing
interventions to promote long-term adherence.
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The biomedical perspective
The biomedical perspective incorporates the biomedical
theory in which patients are assumed to be passive recipi-
ents of doctors' instructions [11]. Health or disease is
traced back to biomedical causes, such as bacteria or
viruses, and treatment is therefore focused on the patient's
body [11]. In keeping with this mechanistic view of ill-
ness, mechanical solutions, such as prescribed pills, are
preferred [12]; non-adherence is understood to be caused
by patient characteristics, such as age and gender [12].
Technological innovations to promote adherence, such as
Medication Event Monitoring Systems ®, are sometimes
rooted in this perspective [7]. However, despite its
implicit use by many health professionals, this perspective
is infrequently used explicitly in interventions.
A fundamental limitation of this theory is that it ignores
factors other than patient characteristics that may impact
on health behaviours – for example, patients' perspectives
of their own illness [7]; psycho-social influences [12]; and
the impacts of the socio-economic environment. The
socio-economic environment or demographics may, how-
ever, be markers for other factors that lend themselves to
intervention even though they themselves cannot be
changed [13]. The danger of using demographics as proxy
variables for adherence is that certain groups that come to
be seen as "lost causes" may be excluded (e.g. [14]). This
biomedical theory has recently been integrated into a
larger "biopsycho-socio-environmental" theory, which
incorporates the wider socio-environmental context [11].
However, this theory is not located strictly within the bio-
medical approach. Due to the assumption that patients
are passive and the focus on biomedical factors, it is
unlikely that the biomedical theory can contribute signif-
icantly to TB or HIV medication adherence. Patients are
generally active decision makers and do not merely receive
and follow instructions passively. No meta-analyses spe-
cifically examining this perspective were identified.
Behavioural (learning) perspective
This perspective incorporates behavioural learning theory
(BLT) which is focused on the environment and the teach-
ing of skills to manage adherence [7]. It is characterised by
the use of the principles of antecedents and consequences
and their influence on behaviour. Antecedents are either
internal (thoughts) or external (environmental cues)
Table 1: Summary of selected health behaviour theories*
Model Author Meta-analyses examining the model Evidence supporting theory
Biomedical None identified (NI)
BLT Skinner, 1953 NI
Communication NI
HBM Rosenstock et al. 1966 1. 30
2. 31
1. 46 studies- substantial empirical support.
2. 16 studies; at best 10% of variance accounted for 
by any one dimension of the theory.
SCT Bandura 1950's 38 27 studies; self-efficacy explained between 4% and 
26% of variance
TRA Fishbein & Ajzen, 1975 41 Theory explains about 25% of variance in behaviour 
from intention alone, and explains slightly less than 
50% of variance in intentions.
TPB Fishbein & Ajzen, 1975 1.43
2. 44
3. 45
1. 13 studies; 75% of interventions effected a 
change in behaviour in desired direction.
2. 56 studies; About a third of the variations in 
behaviour can be explained by the combined effect 
of intention and perceived behavioural control in 
the domain of health.
3. 185 independent empirical tests: combined effect 
of intention and perceived behavioural control 
explained about a third of variation in behaviour. 
Theory can explain 20% of prospective measures of 
actual behaviour.
PMT Rogers, 1975 35 65 studies – Moderate effects in predicting 
behaviour.
Self-regulation Leventhal et al. 1980 NI
IMB Fisher and Fisher 1992 NI
TTM Prochaska & DiClemente 1983 1. 58
2. 59
1. Stage based interventions not more effective at 
increasing smoking cessation than non-stage based 
interventions.
2. 91 independent samples. Results support that 
individuals use all 10 processes of change.
* The studies included in most of these meta-analyses covered a wide range of content areas, most not directly related to adherence behaviour. 
Readers are encouraged to consult the original source for topic coverage.
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while consequences may be punishments or rewards for a
behaviour. The probability of a patient following a spe-
cific behaviour will partially depend on these variables
[7].
Adherence promoting strategies informed by this perspec-
tive, such as patient reminders, have been found to
improve adherence [15]. Several interventions incorporat-
ing elements of BLT have also been reported to be effective
for adherence to long-term medications [4]. However, a
more recent meta-analysis examining adherence to highly
active antiretroviral (ARV) therapy concluded that inter-
ventions with cue dosing and external rewards –
approaches derived from BLT -were as efficacious as those
without [16]. Another randomised controlled trial on
ARVs reported a negative effect when using electronic
reminder systems [17]. Further evidence is therefore
needed on the effectiveness of these types of strategy.
BLT has been critiqued for lacking an individualised
approach and for not considering less conscious influ-
ences on behaviour not linked to immediate rewards [12].
These influences include, for example, past behaviour,
habits, or lack of acceptance of a diagnosis. The theory is
limited, too, by its focus on external influences on behav-
iour. Programme planners should therefore consider care-
fully individuals' perceptions of appropriate rewards
before using such theory to inform programme design.
Interventions drawing on behavioural theory are often
used in combination with other approaches, although sel-
dom explicitly. No meta-analyses were found that exam-
ined this perspective.
Communication perspective
Communication is said to be "the cornerstone of every
patient-practitioner relationship" [[11], p. 56]. This per-
spective suggests that improved provider-client communi-
cation will enhance adherence [7,11] and implies that this
can be achieved through patient education and good
health care worker communication skills – an approach
based on the notion that communication needs to be
clear and comprehensible to be effective. It also places
emphasis on the timing of treatment, instruction and
comprehension. An example of an intervention utilising
this perspective is one that aims to improve client-pro-
vider interaction. Critiques of this perspective argue that it
ignores attitudinal, motivational and interpersonal factors
that may interfere with the reception of the message and
the translation of knowledge into behaviour change [12].
A number of reviews have examined the effects of inter-
ventions including communication elements [18-21].
However, few of these have examined the effects of com-
munication on health behaviours specifically. Two
reviews focusing on interventions to improve provider-cli-
ent communication showed that these can improve com-
munication in consultations, patient satisfaction with care
[18] as well as health outcomes [21]. However, these
reviews also show limited and mixed evidence on the
effects of such interventions on patient health care behav-
iours, such as adherence.
Communication components have been used within sev-
eral adherence interventions but seldom explicitly or as
the main component. Such interventions are unlikely to
succeed in isolation in improving long-term adherence to
medications because of the influence of external factors,
such as the costs of accessing healthcare for treatment.
Communication interventions are also typically restricted
to provider-client interactions and additional social or
financial support may thus be required.
Cognitive perspective
The cognitive perspective includes theories such as the
health belief model (HBM), social-cognitive theory (SCT),
the theories of reasoned action (TRA) and planned behav-
iour (TPB) and the protection motivation theory (PMT).
These theories focus on cognitive variables as part of
behaviour change, and share the assumption that atti-
tudes and beliefs [22], as well as expectations of future
events and outcomes [23], are major determinants of
health related behaviour. In the face of various alterna-
tives, these theories propose, individuals will choose the
action that will lead most likely to positive outcomes.
These theories have noticeable weaknesses, however:
firstly, that non-voluntary factors can affect behaviour
[23]; devoting time to conscious deliberation regarding a
repeated choice also seems uneconomical [22]. Secondly,
these theories do not adequately address the behavioural
skills needed to ensure adherence [7]. Thirdly, these theo-
ries give little attention to the origin of beliefs and how
these beliefs may influence other behaviours [24]. In
Behavioural learning theoryFigure 1
Behavioural learning theory.
Internal antecedents
I should take my 
medicines 
External antecedents
My cell phone reminded 
me to take them 
Behaviour 
Taking medicines 
Consequences 
Side effects 
Wellbeing 
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addition, it has been argued that they ignore other factors
that may impact on adherence behaviour, such as power
relationships and social reputations [25], and the possi-
bility that risk behaviour may involve more than one per-
son [26]. It has also been suggested that they focus on a
single threat and prevention behaviour and do not
include possible additional threats competing for the
individual's attention [24].
Health Belief Model
The HBM views health behaviour change as based on a
rational appraisal of the balance between the barriers to
and benefits of action [12]. According to this model, the
perceived seriousness of, and susceptibility to, a disease
influence individual's perceived threat of disease. Simi-
larly, perceived benefits and perceived barriers influence
perceptions of the effectiveness of health behaviour. In
turn, demographic and socio-psychological variables
influence both perceived susceptibility and perceived seri-
ousness, and the perceived benefits and perceived barriers
to action [1,7]. Perceived threat is influenced by cues to
action, which can be internal (e.g. symptom perception)
or external (e.g. health communication) (Rosenstock,
1974 in [7]).
High-perceived threat, low barriers and high perceived
benefits to action increase the likelihood of engaging in
the recommended behaviour [27]. Generally, all of the
model's components are seen as independent predictors
of health behaviour [28]. Bandura [29] notes, however,
that perceived threats – especially perceived severity –
have a weak correlation with health action and might
even result in avoidance of protective action. Perceived
severity may also not be as important as perceived suscep-
tibility. Recently, self-efficacy was added into the theory
[30], thereby incorporating the need to feel competent
before effecting long-term change [31].
There are two main criticisms of this theory: firstly, the
relationships between these variables have not been
explicitly spelt out [32] and no definitions have been con-
structed for the individual components or clear rules of
combination formulated [28]. It is assumed that the vari-
ables are not moderated by each other and have an addi-
tive effect [32]. If, for example, perceived seriousness is
high and susceptibility is low, it is still assumed that the
likelihood of action will be high -intuitively one might
assume that the likelihood in this case would be lower
than when both of the variables are high [22,32]. The
HBM also assumes that variables affect health behaviour
directly and remain unmoderated by behavioural inten-
tions [22]. The second major weakness of HBM is that
important determinants of health behaviour, such as the
positive effects of negative behaviours and social influ-
ence, are not included [22,32]. In addition, some behav-
iours such as smoking are based on habits rather than
Health belief modelFigure 2
Health belief model.
Perceived 
susceptibility  
I don’t smoke; no lung 
disease in my family
Perceived severity  
TB is a fatal disease 
Perceived benefits  
The medication will  
make me better 
Perceived barriers  
I may experience side 
effects from the 
medication
Belief in a personal 
health threat  
I’ll get over it  
Belief in the 
effectiveness of health 
behaviour
I’m not sure if it will work
Health behaviour  
If it gets worse I will take 
the medication 
Adapted from Stroebe, 2000
BMC Public Health 2007, 7:104 http://www.biomedcentral.com/1471-2458/7/104
Page 6 of 16
(page number not for citation purposes)
decisions [33]. While the theory may predict adherence in
some situations, it has not been found to do so for "risk
reduction behaviours that are more linked to socially
determined or unconscious motivations" [[12], p.165].
The two reviews identified that examined this theory had
inconclusive results. A critical review [34] examined 19
studies which involved sick role behaviours, such as com-
pliance to antihypertensive medication. While the four
dimensions of the model produced significant effects in
most of the studies included [34], the studies had consid-
erable methodological gaps. A more recent meta-analysis
[35] indicated that while the HBM was capable of predict-
ing 10% of variance in behaviour at best, the included
studies were heterogeneous and were unable to support
conclusions as to the validity of the model. Therefore fur-
ther studies are needed to assess the validity of this theory.
When applying this theory to long-term medication
adherence, it is also important for the influence of socio-
psychological factors to be considered. For example, cul-
tural beliefs about TB – such as its relationship with witch-
craft [36] – may reduce an adherence intervention's
effectiveness.
The protection-motivation theory
According to this theory, behaviour change may be
achieved by appealing to an individual's fears. Three com-
ponents of fear arousal are postulated: the magnitude of
harm of a depicted event; the probability of that event's
occurrence; and the efficacy of the protective response
[37]. These, it is contended, combine multiplicatively to
determine the intensity of protection motivation [22],
resulting in activity occurring as a result of a desire to pro-
tect oneself from danger [37]. This is the only theory
within the broader cognitive perspective that explicitly
uses the costs and benefits of existing and recommended
behaviour to predict the likelihood of change [23].
An important limitation of this theory is that not all envi-
ronmental and cognitive variables that could impact on
attitude change (such as the pressure to conform to social
norms) are identified [37]. The most recent version of the
theory assumes that the motivation to protect oneself
from danger is a positive linear function of beliefs that:
the threat is severe, one is personally vulnerable, one can
perform the coping response (self efficacy) and the coping
response is effective (response efficacy) [22]. Beliefs that
health-impairing behaviour is rewarding but that giving it
up is costly are assumed to have a negative effect [22].
However, the subdivision of perceived efficacy into cate-
gories of response and self efficacy is perhaps inappropri-
ate – people would not consider themselves capable of
performing an action without the means to do it [29].
A meta-analysis examining this theory found only moder-
ate effects on behaviour [39]. The revised PMT may be less
cumbersome to use than the TRA – it also does not assume
that behaviour is always rational. [39]. The PMT may be
appropriate for adherence interventions as it is unlikely
that an individual consciously re-evaluates all of their rou-
tine behaviours such as, for example, taking long-term
medication. However, the influence of social, psychologi-
cal and environmental factors on motivation requires
consideration by those using this approach.
Social-cognitive theory
This theory evolved from social learning theory and may
be the most comprehensive theory of behaviour change
developed thus far [1]. It posits a multifaceted causal
structure in the regulation of human motivation, action
and well-being [40] and offers both predictors of adher-
ence and guidelines for its promotion [29]. The basic
organising principle of behaviour change proposed by
this theory is reciprocal determinism in which there is a
continuous, dynamic interaction between the individual,
the environment and behaviour [1].
Social-cognitive theory suggests that while knowledge of
health risks and benefits are a prerequisite to change,
additional self-influences are necessary for change to
occur [41]. Beliefs regarding personal efficacy are among
some of these influences, and these play a central role in
change. Health behaviour is also affected by the expected
outcomes – which may be the positive and negative effects
of the behaviour or the material losses and benefits. Out-
comes may also be social, including social approval or dis-
approval of an action. A person's positive and negative
self-evaluations of their health behaviour and health sta-
tus may also influence the outcome. Other determinants
Protection motivation theoryFigure 3
Protection motivation theory.
Perceived severity 
TB is a killer disease  
Perceived 
probability/perceived 
susceptibility 
Many people around me 
have TB; I could have TB 
Efficacy  
of response 
TB medication  
cures you 
Motivation  
to engage in 
preventive behaviour
Adapted from Rogers, 1975
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of behaviour are perceived facilitators and barriers. Behav-
iour change may be due to the reduction or elimination of
barriers [41]. In sum, this theory proposes that behaviours
are enacted if people perceive that they have control over
the outcome, that there are few external barriers and when
individuals have confidence in their ability to execute the
behaviour [28].
A review reported that self efficacy could explain between
4% and 26% of variance in behaviour [42]. However, this
analysis was limited to studies of exercise behaviour, and
did not include reports that examined SCT as a whole.
Due to its wide-ranging focus, this theory is difficult to
operationalise and is often used only in part [43], thus
raising questions regarding its applicability to interven-
tion development.
Theory of planned behaviour and the theory of reasoned action
The first work in this area was on the TRA [44].
The TRA assumes that most socially relevant behaviours
are under volitional control, and that a person's intention
to perform a particular behaviour is both the immediate
determinant and the single best predictor of that behav-
iour [45]. An intention to perform a behaviour is influ-
enced by attitudes towards the action, including the
individual's positive or negative beliefs and evaluations of
the outcome of the behaviour. It is also influenced by sub-
jective norms, including the perceived expectations of
important others (e.g. family or work colleagues) with
regard to a person's behaviour; and the motivation for a
person to comply with others' wishes. Behavioural inten-
tion, it is contended, then results in action [44]. The
authors argue that other variables besides those described
above can only influence the behaviour if such variables
influence attitudes or subjective norms. A meta-analysis
examining this theory found that it could explain approx-
imately 25% of variance in behaviour in intention alone,
and slightly less than 50% of variance in intentions [45].
This suggests that support for this theory is limited.
Additionally, The TRA omits the fact that behaviour may
not always be under volitional control and the impacts of
past behaviour on current behaviours [22]. Recognising
this, the authors extended the theory to include behav-
ioural control and termed this the TPB. 'Behavioural con-
trol' represents the perceived ease or difficulty of
performing the behaviour and is a function of control
beliefs [45]. Conceptually it is very similar to self-efficacy
[22] and includes knowledge of relevant skills, experience,
Revised protection motivation theoryFigure 4
Revised protection motivation theory.
Adapted from Stroebe, 2000
Severity  
TB is a serious disease
Vulnerability  
If I don’t take my medications 
I will not be well 
Intrinsic rewards 
Not taking the pills is easier  -
If I don’t take the pills no one 
will know I have TB 
Response efficacy  
The tablets make me feel
better- I can remember to 
take all my medication 
Response costs 
I could get side effects 
Protection  
motivation 
Threat  
appraisal 
Coping  
appraisal 
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emotions, past track record and external circumstances
(Ajzen, in [46]). Behavioural control is assumed to have a
direct influence on intention [45]. Meta-analyses examin-
ing the TPB have found varied results regarding the effec-
tiveness of the theory's components [47-49]. Although
not conclusive, the results of the analyses are promising.
Sutton [45] suggests that the TRA and TPB require more
conceptualisation, definition and additional explanatory
factors. Attitudes and intentions can also be influenced by
a variety of factors that are not outlined in the above the-
ories [22]. Specifically, these theories are largely depend-
ent on rational processes [50] and do not allow explicitly
for the impacts of emotions or religious beliefs on behav-
iour, which may be relevant to stigmatised diseases like TB
and HIV/AIDS.
Information-motivation-behavioural skills (IMB) theory
This theory was developed to promote contraceptive use
and prevent HIV transmission. IMB was constructed to be
conceptually based, generalisable and simple [51]. It has
since been tailored specifically to designing interventions
to promote adherence to ART [52]
This theory focuses on three components that result in
behaviour change: information, motivation and behav-
iour skills. Information relates to the basic knowledge
about a medical condition, and is an essential prerequisite
for behaviour change but not necessarily sufficient in iso-
lation [51]. A favourable intervention would establish the
baseline levels of information, and target information
gaps [51]. The second component, motivation, results
from personal attitudes towards adherence; perceived
social support for the behaviour; and the patients' subjec-
tive norm or perception of how others with the condition
might behave [7]. Finally, behavioural skills include fac-
tors such as ensuring that the patient has the skills, tools
and strategies to perform the behaviour as well as a sense
of self-efficacy – the belief that they can achieve the behav-
iour [51].
The components mentioned above need to be directly rel-
evant to the desired behaviour to be effective [7]. They can
also be moderated by a range of contextual factors such as
living conditions and access to health services [52]. Infor-
mation and motivation are thought to activate behav-
ioural skills, which in turn result in risk reduction
behavioural change and maintenance [51]. The theory is
said to be moderately effective in promoting behaviour
change [7], and has been shown to have predictive value
for ART adherence [53]. However, no meta-analyses were
identified that assessed the effects of this model. The
advantage of IMB is its simplicity and its recent applica-
tion to ART adherence suggests that it may be a promising
model for promoting adherence to TB medication.
Self-regulation perspectives
Self-regulatory theory is the main theory in this domain.
Developed to conceptualise the adherence process in a
way that re-focuses on the patient [54], the theory pro-
poses that it is necessary to examine individuals' subjec-
tive experience of health threats to understand the way in
which they adapt to these threats. According to this the-
ory, individuals form cognitive representations of health
threats (and related emotional responses) that combine
new information with past experiences [55]. These repre-
sentations 'guide' their selection of particular strategies for
coping with health threats, and consequently influence
associated outcomes [56]. The theory is based on the
assumption that people are motivated to avoid and treat
illness threats and that people are active, self-regulating
problem solvers [57]. Individuals, it is implicitly assumed,
will endeavour to reach a state of internal equilibrium
through testing coping strategies. The process of creating
health threat representations and choosing coping strate-
gies is assumed to be dynamic and informed by an indi-
vidual's personality, and religious, social and cultural
context [55]. In addition, a complex interplay exists
between environmental perceptions, symptoms and
beliefs about disease causation [54].
The self-regulation theory offers little guidance related to
the design of interventions [7] and no meta-analyses
examining evidence for the effectiveness of this theory
were identified. While the theory seems intuitively appro-
priate, specific suggestions are needed as to how these
processes could promote adherence.
Social cognitive theoryFigure 5
Social cognitive theory.
Behaviour 
Knowledge  
of health risks  
I know what TB is 
Benefits of change 
Taking the medication will 
make me feel better 
Self efficacy  
I can take  
my medication 
Outcome expectations
If I take my medication 
I will feel better 
Facilitators  
and barriers  
It is easy to take  
my medication
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Stage perspectives
The transtheoretical model (TTM)
This theory is most prominent among the stage perspec-
tives. It hypothesizes a number of qualitatively different,
discrete stages and processes of change, and reasons that
people move through these stages, typically relapsing and
revisiting earlier stages before success [58,59]. This theory
is said to offer an "integrative perspective on the structure
of intentional change" [[60], p. 1102] – the perceived
advantages and disadvantages of behaviour are crucial to
behaviour change [61].
The process of change includes independent variables that
assess how people change their behaviour [62] and the
covert and overt activities that help individuals towards
healthier behaviour [63]. Different processes are empha-
sised at different stages.
Criticisms of TTM include the stages postulated and their
coverage and definitions, and descriptors of change.
According to Bandura [40], this theory violates all three of
the basic assumptions of stage theories: qualitative trans-
formations across discrete stages, invariant sequence of
change, and non-reversibility. In addition, the proposed
stages may only be different points on a larger continuum
[29,58,63]. Bandura [29] suggests that human function-
ing is too multifaceted to fit into separate, discrete stages
and argues that stage thinking could constrain the scope
Theory of reasoned actionFigu e 6
Theory of reasoned action.
Adapted from Stroebe, 2000
Attitude  
towards  
action 
Subjective  
norms 
Behavioural 
intention 
Behaviour 
Motivation to comply 
I want to do what  
they want me to do 
Beliefs about the  
outcome of the behaviour 
If I finish the course  
of medication  
I will be healthy
Evaluation of  
expected outcomes 
Being healthy  
is desirable 
Normative beliefs 
My family and friends 
think I should take my 
medication 
Table 2: Recommendations for using health behaviour theories to develop long-term adherence promoting interventions in TB and 
HIV
▪ Future research should focus on the further examination of existing theories.
▪ Further work is required to identify and explore health behaviour theories most applicable to improving adherence to long-term medications.
▪ Existing health behaviour models should be tested systematically.
▪ Interventions utilising health behaviour theories appropriately need to be developed and trialled.
▪ Reports of interventions to promote adherence to long-term medications for other health issues should be reviewed to explore how these have 
drawn on health behaviour theories.
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of change-promoting interventions. Furthermore, TTM
provides little information on how people change and why
only some individuals succeed [28].
Sutton [56] argues that the stage definitions included in
the TTM are logically flawed, and that the time periods
assigned to each stage are arbitrary. Similarly, there is also
a need for more attention to measurement, testing issues
and definition of variables and causal relationships [58].
The coverage and type of processes included may also be
inadequate [63].
The TTM has received much practitioner support over the
years, but less direct research support for its efficacy
[3,10]. The meta-analyses identified for this review did
not offer direct support for the theory; while one found
that individuals use all 10 processes of change [64],
another found that interventions that used the stage per-
spective were not more efficient than those not using the
theory [65]. Further evidence of its efficacy is therefore
needed. A strength of this theory is that it allows interven-
tions to be tailored to individual needs. However, large-
scale implementation of these interventions may be time
consuming, complicated and costly. Its use may be more
appropriate in areas where rapid behaviour change is not
necessary.
Discussion
This review has discussed a number of health behaviour
theories that contribute to understanding adherence to
long-term medications, such as those for TB and HIV/
AIDS.
Although the use of theory to develop interventions to
promote adherence offers several advantages, it also has
some limitations. Firstly, there is little evidence that
allows for the direct comparison of these theories [66].
Combining studies based on even one theory, in order to
perform a meta-analysis to assess its effectiveness in pre-
dicting behaviours, is difficult due to various methodo-
logical problems in the original studies [60]. Furthermore,
the number of theories in this field has proliferated over
Theory of planned behaviourFigu e 7
Theory of planned behaviour.
Behavioural 
intention 
Behaviour 
Beliefs about the  
outcome of the behaviour
If I take the pills  
I will feel better
Evaluation of  
expected outcomes  
Feeling better is good 
Motivation to comply  
I want to do what they 
want me to do 
Normative beliefs  
Family and friends want 
me to take the pills 
Control beliefs
Remembering the 
medicine will be difficult 
Attitude  
towards  
action 
Subjective  
norms 
Perceived 
behavioural 
control 
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time, as theorists have examined different areas of behav-
iour and engaged in re-examining existing explanatory
theories. Researchers, health planners and practitioners
may therefore be overwhelmed by the multitude of theo-
ries available to them and the fragmented, and often con-
tradictory, evidence. Questions also remain regarding the
applicability of these theories to contexts other than those
in which they were developed. Ashing-Giwa [67], for
example, suggests that the above theories do not address
socio-cultural aspects sufficiently. Issues such as the
stigma attached to TB due to its perceived relation to HIV
(especially in developing countries) may impact on the
acceptability and the uptake of interventions. Further
attention should therefore be given to the question of
whether theories developed in the USA and the UK are
applicable to individuals in other contexts where the dis-
ease burden from HIV/AIDS and TB is greatest.
Secondly, health behaviour change theories have tended
to encompass a wide variety of health behaviours, each
qualitatively different. The systematic reviews identified
for this paper included studies ranging from smoking ces-
sation to mothers limiting babies' sugar intake. Particular
theories may be more applicable than others to improving
adherence to specific health behaviours. For example,
adherence to long-term medication will necessarily be dif-
ferent to a behaviour change required to take up exercise.
In addition, achieving adherence to TB medication may
be seen as an urgent issue for public health because of its
infectiousness, and the recent emergence of extremely
drug resistant strains [68]. It is difficult therefore to com-
pare the effects of the theories across health categories or
even within individual categories.
Thirdly, few studies were identified that had examined the
selected health behaviour theories in relation to long-term
medication adherence, or that had developed interven-
tions to promote long-term adherence explicitly based on
these theories, particularly for TB. Sumartojo's [13] assess-
ment that a theory-based approach has largely been
absent within the field of TB behavioural research appears
to remain valid today.
The application of theories to the design of interventions
remains a challenge for researchers and programme plan-
ners [69] and there is considerable debate concerning the
effectiveness and usefulness of theory in informing inter-
vention development (see [2,70,71]). Despite a variety of
studies in a variety of fields, or perhaps because of this var-
iation, we would argue that there is no clear evidence yet
for the support of any of these theories within the field of
adherence behaviours. This is not to say that these theo-
Information motivation behavioural skills modelFigure 8
Information motivation behavioural skills model.
Adherence 
information  
I know what 
taking HAART 
involves 
Adherence 
motivation  
Taking HAART 
will be good for 
me and it will 
ensure I stay 
healthy. 
Adherence 
behavioural skills
I know how to take 
my medication 
correctly 
Adherence
Behaviour 
•Proper dosing 
•Optimal 
adherence 
•Adherence levels 
over time 
Adapted from Fisher et al, 2006  
Health outcomes
• Viral load 
• Drug resistance 
• CD4 counts 
• Objective health 
status 
• Subjective health 
Moderating factors affecting adherence
•Psychological health 
•Living situation 
•Access to medical care services and insurance 
coverage 
•Substance use or addiction 
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ries cannot be useful – rather, we have insufficient evi-
dence to conclusively determine this.
While these discussions continue, research should aim to
shed light on the key questions related to the theory-inter-
vention debate: Do sound theories result in effective inter-
ventions? Does an effective intervention constitute proof
of a theory's value? How might theory be used to inform
the design of an effective intervention? And how can a the-
ory be reliably tested? Some research work has already
been undertaken in these areas: in a systematic review of
antiretroviral treatment adherence interventions, Amico
et al. [72] found that the use of theory in constructing an
intervention did not account for variability in the inter-
vention's efficacy. However, it is unclear how many of the
24 included studies in this review articulated a health
behaviour change theory or the extent to which this was
done.
Two possible approaches have been suggested to address-
ing the difficulties raised by the multitude of existing the-
ories on health behaviour change. One approach is to
attempt to identify variables common to these theories.
This has been undertaken for 33 health behaviour change
theories [7] in order to make psychological theories more
accessible and easier to select. The results of this study pro-
vide some guidance on the most important variables in
psychological theories, and may assist in the further devel-
opment of health behaviour change theories. A second
approach is to attempt to integrate the theories. While
there is a need for such theoretical integration [73], we
argue that researchers and theorists alike should be cau-
tious when picking and choosing parts of other theories to
develop further theories – so-called "cafeteria-style theo-
rizing" – as the resulting theories may include redundant
variables [[29], p. 285].
Because some theories share overlapping variables
describing using different names [8,41], and most differ-
ences are due to an emphasis of one variable over another
[1], it would serve the development of this field to con-
duct studies to identify particular variables that perform
best in predicting behaviour change. For example, in a
meta-analysis of randomised controlled trials testing
antiretroviral treatment adherence interventions, Simoni
[16] found that giving basic information to patients, and
engaging them in discussion about helping them to over-
come cognitive factors, lack of motivation and unrealistic
expectations about adherence, were effective in improving
adherence. Similarly, comparative studies between theo-
ries could be used to identify effective components [74].
The field of health behaviour theory remains dynamic,
Self regulation theoryFigure 9
Self regulation theory.
Adapted from Leventhal, Nerenz & Steele, 1984 
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and it is important to continue developing existing theo-
ries and approaches as new evidence emerges.
Applying health behaviour theories to medication 
adherence for TB and HIV/AIDS
How optimal adherence for TB and HIV/AIDS can be
ensured remains an important question. While large num-
bers of studies have explored patients' and health care
providers' views regarding adherence to TB treatment [75]
or have described programmes to improve adherence to
these medications, there are still relatively few rigorous
evaluations of interventions to promote adherence to TB
and HIV/AIDS treatments [76,77]; even fewer have explic-
itly utilised behaviour change theories. For example, a sys-
tematic review of interventions to promote adherence to
TB treatment [77] included ten trials, none of which used
an explicit theoretical framework. A similar review identi-
fied seven different randomised controlled trials of inter-
ventions to promote adherence to antiretroviral therapy
[76], of which only one employed an explicit theoretical
framework. Similar figures have been reported in other
domains: a review of guideline implementation studies
showed that less than 10% of these provided an explicit
theoretical rationale for their intervention [78]. Given the
paucity of evidence to support any particular health
behaviour theory, we cannot therefore suggest that these
theories be used routinely to design adherence promoting
interventions. However, since these theories may well
have practical behaviour change potential, and since the
problem of medication adherence remains significant for
both clinical medicine and public health, further explora-
tory and explanatory research is needed.
A number of recommendations emerge from this review
(Table 2): firstly, future research should focus not on the
development of new theories but rather on the further
examination of those already elaborated. Several key
attributes that should be encompassed by theories
explaining behaviour change have been suggested, includ-
ing demonstrated effectiveness in predicting and explain-
ing changes in behaviour across a range of domains; an
ability to explain behaviour using modifiable factors; and
an ability to generate clear, testable hypotheses. The theo-
ries should include non-volitional components (i.e. issues
over which individuals do not have complete control)
and take into account the influence of external factors, as
perceived by individuals [2,70].
Secondly, further work is required to identify theories of
health behaviour that are most applicable to improving
adherence to long-term medication. Existing health
behaviour theories should be tested systematically to
establish which best predict effects on different kinds of
behaviour for different groups of people in different con-
texts. For example, does a particular theory predict
changes in adherence behaviour for both men and
women with TB in both England and South Africa? Some
researchers have argued that experimental research and
increased clarity in theories and methods could assist in
the identification of effective behaviour change tech-
niques, thereby contributing to the development of evi-
dence-based practice in health psychology and
implementation research [2,3]. Similar efforts need to be
made regarding the use of theories as applied to adher-
ence behaviour.
Thirdly, the abundance of theories and their poor evi-
dence base highlights the need to develop and trial inter-
ventions that utilise these theories appropriately (i.e. in
concordance with the theory), with well defined and oper-
ationalised variables. This will help to advance the study
of human adherence behaviour and allow for better
informed decisions related to how to these theories could
be more widely applied in practice. (See references [2] and
[75] for guidance on developing theoretically informed
interventions). We have compiled a number of examples
[see additional file 1] of the application of such theories
in practice.
Finally, reports of interventions to promote adherence to
long-term medications for other health issues, such as dia-
betes, asthma and hypertension, should be reviewed to
determine how many have drawn on theory in the design
Transtheoretical modelFigure 10
Transtheoretical model.
Precontemplation
I am not seriously thinking of changing –  
I don’t think I should adhere to my medication 
Contemplation
Seriously, I think I should  
adhere to my medication regimen 
Action
I am trying to remember my medications  
and marking them in the calendar 
Preparation
I am ready to change –  
I am making a reminder calendar 
Maintenance
I have been able to take my  
pills every day for a month 
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and testing of these interventions; the range of theories
utilised and the ways in which this was done; and the
ways in which the use of theory contributed to under-
standing the effects of these interventions. Many reviews
of such interventions exist (for example, see [83,84]) and
these could act as a starting point for such work.
It is also important to list some of the limitations of this
review. Firstly, we have been unable to capture all the
available data on tests of health behaviour theories. Sec-
ondly, this paper examines only theories constructed by
researchers and does not explore the health theories held
by those receiving treatment. These lay theories of adher-
ence with regard to antiretroviral [81] and TB treatment
[75] are discussed elsewhere.
It should also be noted that any understanding of individ-
ual health behaviour, and interventions to change this,
must be located within the relevant social, psychological,
economic and physical environments [28]. Much research
on adherence to TB medication has indicated that poor
adherence is commonly the result of factors outside the
individual's control, including clinic and health care
organisation factors (such as interruptions to drug supply
and long distances to health facilities) and structural fac-
tors (such as poverty and migration) [13,82,83]. Similar
issues have been reported for adherence to ART [84]. Any
focus on changing the behaviours of individuals with TB
or HIV should not result in the neglect of these other
dimensions or the further disadvantaging of the poor and
vulnerable, thereby widening health disparities. Interven-
tions that focus on providers, the provider-patient rela-
tionship, health system and contextual factors therefore
also need to be developed and evaluated [76].
Conclusion
There is no simple solution to the problem of adherence,
or to the area of behaviour change. Health behaviour the-
ories may shed light on the processes underlying behav-
iour change. However, an explicit theoretical basis is not
always necessary for a successful intervention and further
examination is needed to determine whether theory-
based interventions in health care are more effective than
those without an explicit theoretical foundation [2,70].
This review contributes to advancing this field by describ-
ing the commonly cited health behaviour theories, pre-
senting the evidence and critique for each; discussing the
applicability of these theories to adherence behaviour;
and highlighting several recommendations for research
and theory development. To understand and overcome
the barriers to treatment adherence, considerable research
is needed. However, given the importance of long-term
medication adherence to global public health, particularly
in relation to the HIV and TB epidemics, such research
should receive much higher priority.
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